 Iron oxide-enhanced MR imaging liver spleen review first years Superparamagnetic iron oxide SPIO particles potent new class MR contrast agents improved detection hepatic splenic neoplasms report development agent preclinical studies early clinical results Massachusetts General Hospital investigation SPIO particles normal phagocytic Kupffer cells reticuloendothelial system RES tumor tissue fivefold increase relaxation normal RES tissue tumor comparable advantage quantitative signal-to-noise ratio contrast-to-noise ratio lesion detectability liver spleen MR lesion conspicuity threshold size lesion detection mm Clinically beneficial effects variety spin-echo pulse sequences gradient-echo techniques benefit administration SPIO Metabolically pharmaceutical-grade preparations biodegradable bioavailable body iron stores erythrocyte hemoglobin Early dose-escalation clinical trials probable clinical dose range mumols Fe/kg body weight United SPIO date use investigational studies Newer commercial formulations clinical safety margins